Article info

Download PDFPDF
Review
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments

Authors

  • Yoshiki Sekijima Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yoshiki Sekijima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan; sekijima{at}shinshu-u.ac.jp
View Full Text

Citation

Sekijima Y
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments

Publication history

  • Received September 9, 2014
  • Revised December 22, 2014
  • Accepted December 25, 2014
  • First published January 20, 2015.
Online issue publication 
August 13, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.